The complete form of X-linked congenital stationary night blindness (CSNB1A) is a very rare genetic disease caused by mutation in the NYX gene. CSNB1A-associated several mutations in the NYX gene have been reported earlier. In this case report, we have clinically diagnosed and genetically confirmed a novel mutation associated with CSNB1A in four members of a Russian family. Two male siblings from a family of four siblings (two girls, two boys) with non-progressive stable night blindness since early childhood and high myopia underwent - visual acuity test, perimetry, biomicroscopy, OCT, ophthalmoscopy, electroretinography, color vision Hue test, NGS based whole exome analysis and Sanger sequencing for clinical characterization and genetic confirmation of CSNB. The members are clinically diagnosed and genetically confirmed with CSNB1A. All the patients had a novel frameshift mutation in the NYX gene (c.283delC, p.His95fs, NM_022567.2) that is found to segregate in X-linked manner This is probably the first case report with a novel mutation from Russia associated with CSNB1A.

Download full-text PDF

Source
http://dx.doi.org/10.1080/13816810.2019.1698617DOI Listing

Publication Analysis

Top Keywords

night blindness
12
nyx gene
12
novel frameshift
8
frameshift mutation
8
russian family
8
congenital stationary
8
stationary night
8
mutation nyx
8
case report
8
clinically diagnosed
8

Similar Publications

Prevalence of ocular manifestations of vitamin A deficiency in children: A systematic review.

Arch Soc Esp Oftalmol (Engl Ed)

December 2024

Facultad de Medicina, Universidad El Bosque, Bogotá, Colombia. Electronic address:

Objective: Identify the prevalence of ocular manifestations due to vitamin A in children.

Methods: The systematic search was carried out in September 2022. Observational studies with populations between 0-18 years old, who had ocular manifestations due to vitamin A deficiency, were included.

View Article and Find Full Text PDF

Synaptic transmission from photoreceptors to ON-bipolar cells (BCs) requires the postsynaptic metabotropic glutamate receptor mGluR6, located at BC dendritic tips. Binding of the neurotransmitter glutamate initiates G protein signaling that regulates the TRPM1 transduction channel. mGluR6 also interacts with presynaptic ELFN adhesion proteins, and these interactions are important for mGluR6 synaptic localization.

View Article and Find Full Text PDF

Purpose: To report a novel hemizygous nonsense variant in the CACNA1F gene associated with congenital stationary night blindness (CSNB) in a pediatric patient, emphasizing the utility of portable electroretinography (ERG) and genetic testing in diagnosing unexplained visual impairments.

Methods: The patient, a 5-year-old male, underwent comprehensive clinical evaluation, including detailed anterior segment and fundus examinations, full-field electroretinogram (ffERG) using a RETeval™ portable device, and whole exome sequencing (WES) to elucidate the genetic basis of his visual impairment. Structural modeling of the mutated protein was performed using SWISS-MODEL and PYMOL.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines how myopia (nearsightedness) progresses in children with congenital stationary night blindness (CSNB), a type of inherited retinal disorder, to better evaluate potential treatments.
  • The researchers analyzed refraction measurements from 127 CSNB patients between ages 0 and 21, finding that myopia generally develops quickly in early childhood but stabilizes after age 4, with only slight progression thereafter.
  • The findings suggest that children with CSNB have a stable refractive error after age 4, highlighting the need for tailored myopia control approaches for this specific group.
View Article and Find Full Text PDF

Inherited retinal diseases (IRDs) are a clinically and genetically diverse group of progressive degenerative disorders that can result in severe visual impairment or complete blindness. Despite their predominantly monogenic inheritance patterns, the genetic complexity of over 300 identified disease-causing genes presents a significant challenge in correlating clinical phenotypes with genotypes. Achieving a molecular diagnosis is crucial for providing patients with definitive diagnostic clarity and facilitating access to emerging gene-based therapies and ongoing clinical trials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!